Bottom line
FMED vs VIIIX: the short answer
FMED (Fidelity Disruptive Medicine ETF) and VIIIX (Vanguard Institutional Index Fund) are both etfs.
But VIIIX is far broader, holding 517 positions to 70 for FMED, so beyond the top names it adds exposure FMED doesn't have.
VIIIX is cheaper at 0.02% vs 0.5% — a difference of $48 a year per $10,000 invested.
Over five years, VIIIX returned +14.4% a year vs −0.2% for FMED (reporting dates differ).
Updated Nov 19, 2026
FMED vs VIIIX side by side
| FMED | VIIIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Fidelity | Vanguard |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.5% | 0.02% |
| Annual cost per $10k | $50 | $2 |
| 10-yr cost on $10k (prospectus) | $628 | $26 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +9.7% | +17.9% |
| 5-yr return (annualized) | −0.2% | +14.4% |
| 10-yr return (annualized) | — | +14.8% |
| Best quarter | +9.6% | — |
| Worst quarter | −16.2% | — |
| Net assets (fund) | $41.0M | $350.3B |
| Number of holdings | 70 | 517 |
| Portfolio turnover | 49% | 4% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
FMED and VIIIX share none of their top holdings.
FMED top 10
- Fidelity Revere Street Trust — 10.27%
- Ucb Sa — 4.73%
- Lifestance Health Group Inc — 4.27%
- Danaher Corp — 3.42%
- 10x Genomics Inc — 3.11%
- Intuitive Surgical Inc — 2.92%
- Cogent Biosciences Inc — 2.85%
- Alnylam Pharmaceuticals Inc — 2.79%
- Argenx Se — 2.78%
- Legend Biotech Corp — 2.29%
VIIIX top 10
- NVIDIA Corp — 7.51%
- Apple Inc — 6.59%
- Microsoft Corp — 4.29%
- Amazon.com Inc — 3.62%
- Alphabet Inc — 3.25%
- Broadcom Inc — 2.77%
- Alphabet Inc — 2.59%
- Micron Technology Inc — 2.02%
- Meta Platforms Inc — 1.92%
- Tesla Inc — 1.84%
FAQ
What is the difference between FMED and VIIIX?
Which is cheaper, FMED or VIIIX?
Should I own both FMED and VIIIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.